首頁 > 市場調查報告書 > 醫療設備

整形外科

市場調查報告書

商品編碼

1656916

移植片準備系統:市場洞察·競爭情形·市場預測 (～2032年)

Graft Preparation System - Market Insights, Competitive Landscape, and Market Forecast - 2032

出版日期: 2025年01月01日 | 出版商:

DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄圖表

移植準備系統市場規模預計將從 2024 年的 22.8 億美元成長到 2032 年的 31.5 億美元，預測期內的複合年增長率為 4.17%。

對移植準備系統的需求不斷增長主要是受到多種因素的驅動，尤其是骨骼相關疾病和皮膚問題的日益流行。此外，全球手術數量的增加、研發活動的增加以及主要公司之間的合作也是促進移植準備系統市場良性循環的主要因素。這些因素共同推動了對移植物準備系統的需求，從而在預測期內促進了良好的成長前景。

移植準備系統的市場動態：

根據2023年世界衛生組織（WHO）的數據，2019年全球估計有5.28億人患有骨關節炎。移植物準備系統用於治療骨關節炎的骨關節移植的準備，從而推動市場成長。

根據世界衛生組織（WHO）2023年發布的數據，2019年全球約有1,800萬人患有類風濕性關節炎。數據也顯示，2019年類風濕關節炎患者中70%為女性，55%年齡超過55歲。關節炎、骨質疏鬆症和類風濕性關節炎等骨相關疾病的發生率不斷上升，預計將促使對移植準備系統的需求增加，以準備有助於骨缺損和骨折癒合的組織移植物。

按類型劃分，預計骨移植部分將在 2024 年佔據主要收入佔有率。這是因為骨骼相關疾病的發生率不斷上升，需要透過移植系統來恢復骨骼功能。軟組織和骨移植主要用於韌帶重建和膝關節置換手術，可以使用移植準備裝置進行採集和準備，然後準備植入手術部位。市場領先的公司正在開發先進的技術來執行安全的 ACL 手術。

按地區劃分，預計北美將在 2024 年佔據最大的市場佔有率。這是由於運動相關傷害的增加。此外，該地區老年人口的增加也是推動北美移植準備系統市場成長的主要因素。

本報告提供全球移植片準備系統的市場調查，彙整市場概要，市場影響因素及市場機會分析，法律制度，市場規模的轉變·預測，各種區分·地區/各主要國家的詳細分析，競爭情形，主要企業簡介等資訊。

CONMED Corporation
Integra LifeSciences
Arthrex, Inc.
Stryker
Endologix LLC
Zimmer Biomet
Medtronic
Smith+Nephew
NOUVAG AG
Abbvie Inc.
CosmoBiomediCare
Terumo Corporation
Surtex Instruments Limited
Artivion, Inc.
De Soutter Medical
GR Bioure Surgical System Private Limited
LifeNet Health
BioTek
Johnson & Johnson Services, Inc.
AVITA Medical, Inc.

第9章 KOL的見解

第10章計劃的方法

第11章關於DelveInsight

第12章免責聲明·聯絡方式

簡介目錄圖表

Product Code: DIMDCL0855

Graft Preparation System Market by Type (Skin Grafting System, Soft Tissue Grafting System, and Bone Grafting System), Application (ACL Reconstruction, PCL Reconstruction, Meniscus Repair and Reconstruction, Soft Tissue Repair, and Others), End-User (Hospitals & Clinics, Academic and Research Institutes, Aesthetic Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR Forecast till 2032 owing to the growing prevalence of bone-related disorders and rise in number of surgeries performed in the world

The graft preparation system market was valued at USD 2.28 billion in 2024, growing at a CAGR of 4.17% during the forecast period from 2025 to 2032 to reach USD 3.15 billion by 2032. The growing need for graft preparation systems is witnessing significant growth, driven by several factors. The increasing prevalence of bone-related disorders and skin problems is a primary driver. Additionally, rise in the number of surgeries performed in the world and the growing R&D activities, partnerships among key players are key contributors to the positive trajectory of the graft preparation system market. These factors collectively propel the demand for graft preparation systems, fostering a favorable growth outlook during the forecast period from 2025 to 2032.

Graft Preparation System Market Dynamics:

According to data from the World Health Organization (WHO) in 2023, an estimated 528 million individuals were living with osteoarthritis in 2019 across the globe. A graft preparation system is used in the preparation of osteoarticular allograft for the treatment of osteoarthritis, thereby driving the market growth.

The data published by World Health Organization (WHO) in 2023, indicate that about 18 million individuals suffered from rheumatoid arthritis in 2019 around the world. The data also revealed that 70% of those affected by rheumatoid arthritis in 2019 were women, with 55% being over the age of 55. As a result of the increasing prevalence of bone-related disorders like arthritis, osteoporosis, and rheumatoid arthritis, there will be a growing demand for graft preparation systems to prepare tissue grafts that aid in the healing of bone defects and fractures. This trend is expected to contribute to the positive growth of the graft preparation system market.

The graft preparation system is utilized in plastic surgery to prepare skin grafts for covering damaged skin using tissue sourced from other areas of the body. Similarly, bone grafting involves surgically transplanting bone material to repair and reconstruct bones affected by disease or injury, offering a viable solution for bone restoration across various anatomical sites. Graft preparation devices and instruments are extensively employed for the preparation of soft tissue to address damaged skin, wound care, and bone restoration needs.

Key players in the market are concentrating their efforts on developing and commercialization of novel graft systems to increase graft harvesting to reduce morbidity during minimally invasive surgery. For instance, in August 2022, Orthofix Medical Inc., a US-based medical device company announced its strategic research partnership with CGBio which is a synthetic bone graft development company. Under this partnership, both companies collaborate on the clinical advancement and marketing of Novosis, a recombinant human bone morphogenetic protein-2 (rhBMP-2) bone growth material, along with potential future tissue regenerative solutions, targeting the markets of the United States and Canada.

However, the high initial investment in development and maintenance costs, and the regulatory hurdles and compliance issues, among others are some of the key constraints that may limit the growth of the graft preparation system market.

Graft Preparation System Market Segment Analysis:

In the type segment, the bone grafting system category is estimated to amass a significant revenue share in the graft preparation system market in 2024. This is attributed to the rising prevalence of bone-related disorders that require a grafting system for the restoration of bone function. Soft tissue and bone grafts mainly utilized in ligament reconstruction and knee replacement can be harvested and prepared by grafting devices to make graft ready to implant at the site of surgery. Major players in the market are developing advanced procedures to perform secure ACL procedures. For instance, in March 2023, Smith+Nephew, a UK-based medical technology company, launched the UltraTRAC QUAD ACL Reconstruction Technique, a comprehensive solution comprising the innovative QUADTRAC Quadriceps Tendon Harvest Guide System, the X-WING Graft Preparation System, and a range of ULTRABUTTON Adjustable Fixation Devices. The QUADTRAC System represents a groundbreaking advancement as the premier integrated guide system for minimally invasive quadriceps graft harvesting. This innovative system offers direct visualization of the tendon while facilitating a controlled and consistent technique for harvesting.

Within the graft system, hamstring tendon grafts emerge as a prevalent choice for ACL reconstruction procedures. Typically harvested from the ipsilateral leg, the semitendinosus tendon, often combined with the gracilis tendon, serves as the primary source. These grafts are typically configured into quadruple-stranded constructs and are recognized for their similarity to the native ACL in terms of performance and biomechanical properties. According to Smith+Nephew in 2023, estimations indicate that the volume of ACL procedures in was exceed 350,000 cases in 2023 in the United States, with a forecasted continued growth rate of 5.7% compounded annually.

Therefore, the rising use of bone grafts which require a bone graft preparation system, and the development of advanced procedures by key players contribute to the growth of the segment, thereby driving the growth of the graft preparation system market during the forecast period.

North America is expected to dominate the Overall Graft Preparation System Market:

North America is expected to account for the largest market share in the graft preparation system market in 2024. This can be attributed to the rising number of sports-related injuries. Additionally, the growing geriatric population in the region is the key factor driving the growth of the graft preparation system market in North America.

According to a study published by the American Academy of Orthopedic Surgeons in 2023, titled "Epidemiology of sports injuries among high school athletes in the United States," uncovered that between 2015 and 2019, there were 15,531 injuries documented from 6,778,209 athletic exposures (AE). This translated to an overall injury rate of 2.29 injuries per 1,000 athletic exposures in the United States. This notable increase in sports-related injuries creates an increasing demand for tissue grafts in the United States, thereby contributing to the growth of the graft preparation system market in North America.

Data published by the Population Reference Bureau in January 2024, reported that the number of Americans aged 65 and above is projected to grow significantly, from 58 million in 2022 to 82 million by 2050, a 47% increase. Older people are more prone to tissue damage due to age-related tissue degeneration that can be cured by tissue allografts, which consequently propel the growth of the graft preparation system.

Therefore, the increasing sports-related injuries and the rising geriatric population are key factors driving the growth of the graft preparation system market in North America.

Graft Preparation System Market Key Players:

Some of the key market players operating in the graft preparation system market include CONMED Corporation, Integra LifeSciences, Arthrex, Inc., Stryker, Endologix LLC, Zimmer Biomet, Medtronic, Smith+Nephew, NOUVAG AG, Abbvie Inc., CosmoBiomediCare, Terumo Corporation, Surtex Instruments Limited, Artivion, Inc., De Soutter Medical, GR Bioure Surgical System Private Limited, LifeNet Health, BioTek, Johnson & Johnson Services, Inc., AVITA Medical, Inc., and others.

Recent Developmental Activities in the Graft Preparation System Market:

In June 2023, AVITA Medical, Inc., a US-based regenerative medicine company announced that the U.S. Food and Drug Administration (FDA) granted premarket approval (PMA), allowing the utilization of its RECELL(R) System for the treatment of full-thickness skin defects. The system is a device for harvesting autologous cells, which prepares, produces, and administers a regenerative cell suspension known as Spray-On Skin(TM) Cells, utilizing a small quantity of the patient's skin.
In March 2023, LifeNet Health, a US-based regenerative medicine company launched ViviGen MIS, a graft delivery system used in trauma procedures. ViviGen MIS comprises a pre-filled cannula and a sterile delivery device. This apparatus facilitates the efficient, reliable, and precise administration of ViviGen, a viable bone allograft, while ensuring exceptional clinical outcomes are maintained.

Key Takeaways from the Graft Preparation System Market Report Study

Market size analysis for current Graft Preparation System Market size (2024), and market forecast for 8 years (2025 to 2032)
Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
Key companies dominating the global Graft Preparation System market.
Various opportunities available for the other competitors in the Graft Preparation System Market space.
What are the top-performing segments in 2024? How these segments will perform in 2032?
Which are the top-performing regions and countries in the current Graft Preparation System market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for Graft Preparation System market growth in the coming future?

Target Audience who can be benefited from this Graft Preparation System Market Report Study

Graft Preparation System product providers
Research organizations and consulting companies
Graft Preparation System related organizations, associations, forums, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and Traders dealing in Graft Preparation System
Various end-users who want to know more about the Graft Preparation System Market and the latest technological developments in the Graft Preparation System Market.

Frequently asked questions for the Graft Preparation System Market:

1. What are Graft Preparation System?

A Graft Preparation System is a specialized set of tools and equipment used in medical procedures to prepare tissue grafts for transplantation. These systems streamline the process by facilitating the harvesting, processing, and shaping of graft materials to ensure optimal compatibility and integration with the recipient site. They are essential in surgeries such as orthopedic procedures, plastic surgery, and cardiovascular surgeries, where tissue grafts are commonly used to repair or replace damaged tissues.

2. What is the market for the Graft Preparation System?

The graft preparation system market was valued at USD 2.28 billion in 2024, growing at a CAGR of 4.17% during the forecast period from 2025 to 2032 to reach USD 3.15 billion by 2032.

3. What are the drivers for the global Graft Preparation System market?

The graft preparation system market is expected to witness growth owing to factors such as the increasing prevalence of bone-related disorders and skin problems. Additionally, the rise in the number of surgeries performed in the world and the growing R&D activities and partnerships among key players are key contributors to the positive trajectory of the graft preparation system market. These factors collectively propel the demand for graft preparation systems, fostering a favorable growth outlook during the forecast period from 2025 to 2032.

4. Who are the key players operating in the global Graft Preparation System market?

Some of the key market players operating in the graft preparation system include CONMED Corporation, Integra LifeSciences, Arthrex, Inc., Stryker, Endologix LLC, Zimmer Biomet, Medtronic, Smith+Nephew, NOUVAG AG, Abbvie Inc., CosmoBiomediCare, Terumo Corporation, Surtex Instruments Limited, Artivion, Inc., De Soutter Medical, GR Bioure Surgical System Private Limited, LifeNet Health, BioTek, Johnson & Johnson Services, Inc., AVITA Medical, Inc., and others.

5. Which region has the highest share in the global Graft Preparation System market?

North America is expected to account for the largest market share in the graft preparation system market in 2024. This can be attributed to the rising number of sports-related injuries. Additionally, the growing geriatric population in the region is the key factor driving the growth of the graft preparation system market in North America.

1. Graft Preparation System Market Report Introduction

1.1. Scope of the Study
1.2. Market Segmentation
1.3. Market Assumption

2. Graft Preparation System Market Executive Summary

2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

4.1. The United States
4.2. Europe
4.3. Japan
4.4. China

5. Graft Preparation System Market Key Factors Analysis

5.1. Graft Preparation System Market Drivers
- 5.1.1. The increasing prevalence of bone-related disorders and skin problems
- 5.1.2. The rise in the number of surgeries performed in the world
- 5.1.3. The growing R&D activities and partnerships among key players
5.2. Graft Preparation System Market Restraints and Challenges
- 5.2.1. High initial investment in development and maintenance costs
- 5.2.2. Regulatory hurdles and compliance issues
5.3. Graft Preparation System Market Opportunity
- 5.3.1. Integration of AI in graft preparation devices

6. Graft Preparation System Market Porter's Five Forces Analysis

6.1. Bargaining Power of Suppliers
6.2. Bargaining Power of Consumers
6.3. Threat of New Entrants
6.4. Threat of Substitutes
6.5. Competitive Rivalry

7. Graft Preparation System Market Assessment

7.1. By Type
- 7.1.1. Skin Grafting System
- 7.1.2. Soft Tissue Grafting System
- 7.1.3. Bone Grafting System
7.2. By Application
- 7.2.1. ACL Reconstruction
- 7.2.2. PCL Reconstruction
- 7.2.3. Meniscus Repair and Reconstruction
- 7.2.4. Soft Tissue Repair
- 7.2.5. Others
7.3. By End-User
- 7.3.1. Hospitals and Clinics
- 7.3.2. Academic and research institutes
- 7.3.3. Aesthetic Centers
- 7.3.4. Others
7.4. By Geography
- 7.4.1. North America
  - 7.4.1.1. United States Graft Preparation System Market Size in USD million (2022-2032)
  - 7.4.1.2. Canada Graft Preparation System Market Size in USD million (2022-2032)
  - 7.4.1.3. Mexico Graft Preparation System Market Size in USD million (2022-2032)
- 7.4.2. Europe
  - 7.4.2.1. France Graft Preparation System Market Size in USD million (2022-2032)
  - 7.4.2.2. Germany Graft Preparation System Market Size in USD million (2022-2032)
  - 7.4.2.3. United Kingdom Graft Preparation System Market Size in USD million (2022-2032)
  - 7.4.2.4. Italy Graft Preparation System Market Size in USD million (2022-2032)
  - 7.4.2.5. Spain Graft Preparation System Market Size in USD million (2022-2032)
  - 7.4.2.6. Rest of Europe Graft Preparation System Market Size in USD million (2022-2032)
- 7.4.3. Asia-Pacific
  - 7.4.3.1. China Graft Preparation System Market Size in USD million (2022-2032)
  - 7.4.3.2. Japan Graft Preparation System Market Size in USD million (2022-2032)
  - 7.4.3.3. India Graft Preparation System Market Size in USD million (2022-2032)
  - 7.4.3.4. Australia Graft Preparation System Market Size in USD million (2022-2032)
  - 7.4.3.5. South Korea Graft Preparation System Market Size in USD million (2022-2032)
  - 7.4.3.6. Rest of Asia-Pacific Graft Preparation System Market Size in USD million (2022-2032)
- 7.4.4. Rest of the World (RoW)
  - 7.4.4.1. Middle East Graft Preparation System Market Size in USD million (2022-2032)
  - 7.4.4.2. Africa Graft Preparation System Market Size in USD million (2022-2032)
  - 7.4.4.3. South America Graft Preparation System Market Size In USD Million (2022-2032)

8. Graft Preparation System Market Company and Product Profiles

8.1. CONMED Corporation
- 8.1.1. Company Overview
- 8.1.2. Company Snapshot
- 8.1.3. Financial Overview
- 8.1.4. Product Listing
- 8.1.5. Entropy
8.2. Integra LifeSciences
- 8.2.1. Company Overview
- 8.2.2. Company Snapshot
- 8.2.3. Financial Overview
- 8.2.4. Product Listing
- 8.2.5. Entropy
8.3. Arthrex, Inc.
- 8.3.1. Company Overview
- 8.3.2. Company Snapshot
- 8.3.3. Financial Overview
- 8.3.4. Product Listing
- 8.3.5. Entropy
8.4. Stryker
- 8.4.1. Company Overview
- 8.4.2. Company Snapshot
- 8.4.3. Financial Overview
- 8.4.4. Product Listing
- 8.4.5. Entropy
8.5. Endologix LLC
- 8.5.1. Company Overview
- 8.5.2. Company Snapshot
- 8.5.3. Financial Overview
- 8.5.4. Product Listing
- 8.5.5. Entropy
8.6. Zimmer Biomet
- 8.6.1. Company Overview
- 8.6.2. Company Snapshot
- 8.6.3. Financial Overview
- 8.6.4. Product Listing
- 8.6.5. Entropy
8.7. Medtronic
- 8.7.1. Company Overview
- 8.7.2. Company Snapshot
- 8.7.3. Financial Overview
- 8.7.4. Product Listing
- 8.7.5. Entropy
8.8. Smith+Nephew
- 8.8.1. Company Overview
- 8.8.2. Company Snapshot
- 8.8.3. Financial Overview
- 8.8.4. Product Listing
- 8.8.5. Entropy
8.9. NOUVAG AG
- 8.9.1. Company Overview
- 8.9.2. Company Snapshot
- 8.9.3. Financial Overview
- 8.9.4. Product Listing
- 8.9.5. Entropy
8.10. Abbvie Inc.
- 8.10.1. Company Overview
- 8.10.2. Company Snapshot
- 8.10.3. Financial Overview
- 8.10.4. Product Listing
- 8.10.5. Entropy
8.11. CosmoBiomediCare
- 8.11.1. Company Overview
- 8.11.2. Company Snapshot
- 8.11.3. Financial Overview
- 8.11.4. Product Listing
- 8.11.5. Entropy
8.12. Terumo Corporation
- 8.12.1. Company Overview
- 8.12.2. Company Snapshot
- 8.12.3. Financial Overview
- 8.12.4. Product Listing
- 8.12.5. Entropy
8.13. Surtex Instruments Limited
- 8.13.1. Company Overview
- 8.13.2. Company Snapshot
- 8.13.3. Financial Overview
- 8.13.4. Product Listing
- 8.13.5. Entropy
8.14. Artivion, Inc.
- 8.14.1. Company Overview
- 8.14.2. Company Snapshot
- 8.14.3. Financial Overview
- 8.14.4. Product Listing
- 8.14.5. Entropy
8.15. De Soutter Medical
- 8.15.1. Company Overview
- 8.15.2. Company Snapshot
- 8.15.3. Financial Overview
- 8.15.4. Product Listing
- 8.15.5. Entropy
8.16. GR Bioure Surgical System Private Limited
- 8.16.1. Company Overview
- 8.16.2. Company Snapshot
- 8.16.3. Financial Overview
- 8.16.4. Product Listing
- 8.16.5. Entropy
8.17. LifeNet Health
- 8.17.1. Company Overview
- 8.17.2. Company Snapshot
- 8.17.3. Financial Overview
- 8.17.4. Product Listing
- 8.17.5. Entropy
8.18. BioTek
- 8.18.1. Company Overview
- 8.18.2. Company Snapshot
- 8.18.3. Financial Overview
- 8.18.4. Product Listing
- 8.18.5. Entropy
8.19. Johnson & Johnson Services, Inc.
- 8.19.1. Company Overview
- 8.19.2. Company Snapshot
- 8.19.3. Financial Overview
- 8.19.4. Product Listing
- 8.19.5. Entropy
8.20. AVITA Medical, Inc.
- 8.20.1. Company Overview
- 8.20.2. Company Snapshot
- 8.20.3. Financial Overview
- 8.20.4. Product Listing
- 8.20.5. Entropy